RxDoctor Payments Data

Ashley Parks

Family · Mount Vernon, MONPI 1942966999

Payments from drug & device makers

$521in general payments, 2019–2025

Across 25 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$177
  • Novo Nordisk$113
  • Astellas Pharma US Inc$52
  • Organogenesis Inc.$31
  • Otsuka America Pharmaceutical, Inc.$26
  • Lilly USA, LLC$25
  • plus $96 from 6 others

What the payments were for

  • Food & beverage$521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$521 in reported general payments places this provider in the 55th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$22,894
Medicare patients
68
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$22,841
TrulicityDulaglutide16$21,967
EliquisApixaban18$18,657
OzempicSemaglutide14$12,755
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,296
Xigduo XrDapaglifloz Propaned/Metformin12$6,872
MyrbetriqMirabegron12$5,432
SymbicortBudesonide/Formoterol Fumarate12$2,782
Albuterol Sulfate HfaAlbuterol Sulfate93$2,296
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$1,753
Gabapentin123$1,273
Omeprazole110$1,141
Atorvastatin Calcium191$1,067
Duloxetine Hcl45$778
Fluticasone Propionate72$697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$25$21,96716 claims
PfizerEliquis$14$18,65718 claims
Novo NordiskOzempic$113$12,75514 claims
Astellas Pharma US IncMyrbetriq$52$5,43212 claims
AstraZenecaSymbicort$14$2,78212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,812 family providers in Missouri.

Other family in Mount Vernon

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →